Literature DB >> 16844674

Causes of death among patients with chronic fatigue syndrome.

Leonard A Jason1, Karina Corradi, Sara Gress, Sarah Williams, Susan Torres-Harding.   

Abstract

Chronic fatigue syndrome (CFS) is a debilitating illness affecting thousands of individuals. At the present time, there are few studies that have investigated causes of death for those with this syndrome. The authors analyzed a memorial list tabulated by the National CFIDS Foundation of 166 deceased individuals who had had CFS. There were approximately three times more women than men on the list. The three most prevalent causes of death were heart failure, suicide, and cancer, which accounted for 59.6% of all deaths. The mean age of those who died from cancer and suicide was 47.8 and 39.3 years, respectively, which is considerably younger than those who died from cancer and suicide in the general population. The implications of these findings are discussed.

Entities:  

Mesh:

Year:  2006        PMID: 16844674     DOI: 10.1080/07399330600803766

Source DB:  PubMed          Journal:  Health Care Women Int        ISSN: 0739-9332


  23 in total

1.  Protective effects of selective and non-selective cyclooxygenase inhibitors in an animal model of chronic stress.

Authors:  Anil Kumar; Beenta Kumari; Puneet Kumar
Journal:  Neurosci Bull       Date:  2010-02       Impact factor: 5.203

2.  Mortality in Patients with Myalgic Encephalomyelitis and Chronic Fatigue Syndrome.

Authors:  Stephanie L McManimen; Andrew R Devendorf; Abigail A Brown; Billie C Moore; James H Moore; Leonard A Jason
Journal:  Fatigue       Date:  2016-10-12

Review 3.  The Role of Kynurenine Pathway and NAD+ Metabolism in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Authors:  Mona Dehhaghi; Hamed Kazemi Shariat Panahi; Bahar Kavyani; Benjamin Heng; Vanessa Tan; Nady Braidy; Gilles J Guillemin
Journal:  Aging Dis       Date:  2022-06-01       Impact factor: 9.968

4.  Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26.

Authors:  Mary A Fletcher; Xiao R Zeng; Kevin Maher; Silvina Levis; Barry Hurwitz; Michael Antoni; Gordon Broderick; Nancy G Klimas
Journal:  PLoS One       Date:  2010-05-25       Impact factor: 3.240

Review 5.  Chronic fatigue syndrome: Harvey and Wessely's (bio)psychosocial model versus a bio(psychosocial) model based on inflammatory and oxidative and nitrosative stress pathways.

Authors:  Michael Maes; Frank N M Twisk
Journal:  BMC Med       Date:  2010-06-15       Impact factor: 8.775

6.  A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome.

Authors:  David R Strayer; William A Carter; Bruce C Stouch; Staci R Stevens; Lucinda Bateman; Paul J Cimoch; Charles W Lapp; Daniel L Peterson; William M Mitchell
Journal:  PLoS One       Date:  2012-03-14       Impact factor: 3.240

Review 7.  Elements of Suffering in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Experience of Loss, Grief, Stigma, and Trauma in the Severely and Very Severely Affected.

Authors:  Patricia A Fennell; Nancy Dorr; Shane S George
Journal:  Healthcare (Basel)       Date:  2021-05-09

Review 8.  Identifying and Managing Suicidality in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Authors:  Lily Chu; Meghan Elliott; Eleanor Stein; Leonard A Jason
Journal:  Healthcare (Basel)       Date:  2021-05-25

9.  Suicidal ideation in non-depressed individuals: The effects of a chronic, misunderstood illness.

Authors:  Andrew R Devendorf; Stephanie L McManimen; Leonard A Jason
Journal:  J Health Psychol       Date:  2018-07-11

10.  Risk factors for suicide in chronic fatigue syndrome.

Authors:  Madeline L Johnson; Joseph Cotler; Julia M Terman; Leonard A Jason
Journal:  Death Stud       Date:  2020-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.